Search Results - "Walsh, T. J"

Refine Results
  1. 1

    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy by Moriyama, B, Obeng, A Owusu, Barbarino, J, Penzak, SR, Henning, SA, Scott, SA, Agúndez, JAG, Wingard, JR, McLeod, HL, Klein, TE, Cross, SJ, Caudle, KE, Walsh, TJ

    Published in Clinical pharmacology and therapeutics (01-07-2017)
    “…Voriconazole, a triazole antifungal agent, demonstrates wide interpatient variability in serum concentrations, due in part to variant CYP2C19 alleles…”
    Get full text
    Journal Article
  2. 2

    Laboratory diagnosis of invasive aspergillosis by Hope, W W, Walsh, T J, Denning, D W

    Published in The Lancet infectious diseases (01-10-2005)
    “…Invasive aspergillosis occurs in a wide range of clinical scenarios, is protean in its manifestations, and is still associated with an unacceptably high…”
    Get more information
    Journal Article
  3. 3

    Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases by Roden, Maureen M., Zaoutis, Theoklis E., Buchanan, Wendy L., Knudsen, Tena A., Sarkisova, Tatyana A., Schaufele, Robert L., Sein, Michael, Sein, Tin, Chiou, Christine C., Chu, Jaclyn H., Kontoyiannis, Dimitrios P., Walsh, Thomas J.

    Published in Clinical infectious diseases (01-09-2005)
    “…Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the…”
    Get full text
    Journal Article
  4. 4

    Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints by Pfaller, M.A, Diekema, D.J, Ostrosky-Zeichner, L, Rex, J.H, Alexander, B.D, Andes, D, Brown, S.D, Chaturvedi, V, Ghannoum, M.A, Knapp, C.C, Sheehan, D.J, Walsh, T.J

    Published in Journal of Clinical Microbiology (01-08-2008)
    “…The CLSI Antifungal Subcommittee followed the M23-A2 "blueprint" to develop interpretive MIC breakpoints for anidulafungin, caspofungin, and micafungin against…”
    Get full text
    Journal Article
  5. 5

    Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay by Wheat, L. J., Walsh, T. J.

    “…Invasive aspergillosis is a serious and often fatal infection in patients who are neutropenic or have undergone solid organ or stem cell transplantation…”
    Get full text
    Journal Article
  6. 6

    Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints by Pfaller, M. A, Diekema, D. J, Rex, J. H, Espinel-Ingroff, A, Johnson, E. M, Andes, D, Chaturvedi, V, Ghannoum, M. A, Odds, F. C, Rinaldi, M. G, Sheehan, D. J, Troke, P, Walsh, T. J, Warnock, D. W

    Published in Journal of Clinical Microbiology (01-03-2006)
    “…Developing interpretive breakpoints for any given organism-drug combination requires integration of the MIC distribution, pharmacokinetic and pharmacodynamic…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Validation of the Fournier's gangrene severity index in a large contemporary series by Corcoran, A T, Smaldone, M C, Gibbons, E P, Walsh, T J, Davies, B J

    Published in The Journal of urology (01-09-2008)
    “…In this study we identified prognostic factors for survival and validated the accuracy of the Fournier's gangrene severity index in patients with Fournier's…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis by Zaoutis, Theoklis E., Argon, Jesse, Chu, Jaclyn, Berlin, Jesse A., Walsh, Thomas J., Feudtner, Chris

    Published in Clinical infectious diseases (01-11-2005)
    “…Background. Candida species are the fourth most common cause of bloodstream infection and are the leading cause of invasive fungal infection among hospitalized…”
    Get full text
    Journal Article
  12. 12

    Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program by Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G., Warnock, D. W.

    Published in Medical mycology (Oxford) (2005)
    “…The incidence of invasive aspergillosis was estimated among 4621 hematopoietic stem cell transplants (HSCT) and 4110 solid organ transplants (SOT) at 19 sites…”
    Get full text
    Journal Article
  13. 13

    Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-Like Receptor 2 Induction but Display Relative Resistance to Oxidative Damage by CHAMILOS, G, LEWIS, R. E, LAMARIS, G, WALSH, T. J, KONTOYIANNIS, D. P

    Published in Antimicrobial Agents and Chemotherapy (01-02-2008)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study by ESPINEL-INGROFF, A, FOTHERGILL, A, PETER, J, RINALDI, M. G, WALSH, T. J

    Published in Journal of Clinical Microbiology (01-09-2002)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  15. 15

    Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases by Steinbach, William J., Benjamin, Daniel K., Kontoyiannis, Dimitrios P., Perfect, John R., Lutsar, Irja, Marr, Kieren A., Lionakis, Michail S., Torres, Harrys A., Jafri, Hasan, Walsh, Thomas J.

    Published in Clinical infectious diseases (15-07-2004)
    “…Current in vitro and in vivo data indicate that invasive aspergillosis due to Aspergillus terreus is resistant to treatment with amphotericin B. Because little…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates by Cohen‐Wolkowiez, M, Benjamin, DK, Piper, L, Cheifetz, IM, Moran, C, Liu, P, Aram, J, Kashuba, ADM, Capparelli, E, Walsh, TJ, Hope, WW, Smith, PB

    Published in Clinical pharmacology and therapeutics (01-05-2011)
    “…Candida infections are common and often fatal in infants and neonates. Anidulafungin has excellent activity against Candida species, but the pharmacokinetics…”
    Get full text
    Journal Article
  18. 18

    Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants by Benjamin, D K, Smith, P B, Arrieta, A, Castro, L, Sánchez, P J, Kaufman, D, Arnold, L J, Kovanda, L L, Sawamoto, T, Buell, D N, Hope, W W, Walsh, T J

    Published in Clinical pharmacology and therapeutics (01-01-2010)
    “…Given the risk of central nervous system infection, relatively high weight‐based echinocandin dosages may be required for the successful treatment of invasive…”
    Get full text
    Journal Article
  19. 19

    Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases by Walsh, Thomas J., Hiemenz, John W., Seibel, Nita L., Perfect, John R., Horwith, Gary, Lee, Lily, Silber, Jeffrey L., DiNubile, Mark J., Reboli, Annette, Bow, Eric, Lister, John, Anaissie, Elias J.

    Published in Clinical infectious diseases (01-06-1998)
    “…The safety and antifungal efficacy of amphotericin B lipid complex (ABLC) were evaluated in 556 cases of invasive fungal infection treated through an…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Infections due to emerging and uncommon medically important fungal pathogens by Walsh, T.J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., Anaissie, E.

    Published in Clinical microbiology and infection (01-03-2004)
    “…The emergence of less common but medically important fungal pathogens contributes to the rate of morbidity and mortality, especially in the increasingly…”
    Get full text
    Journal Article